Overview of the effects of cancer therapies: The nature, scale and breadth of the problem

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 433, 1999, Pages 1-4

  Sklar, C A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer; Chemotherapy; Endocrine; Radiation

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CONFERENCE PAPER; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOTHYROIDISM; OVARY DISEASE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CAUSE OF DEATH; CHILD; HUMANS; NEOPLASMS; RADIOTHERAPY; SURVIVORS; TIME FACTORS;

EID: 0033432714     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK. SEER cancer statistics review, 1973-1992: tables and graphs. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1995 Publication No.: NIH-NCI-96-2789
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998; 48: 6-29
3. Marina N. Long-term survivors of childhood cancer. The medical consequences of cure. Pediatr Clin North Am 1997; 44: 1021-42
4. Boulad F, Sands S, Sklar C. Late complications after bone marrow transplantation in children and adolescents. Curr Probl Pediatr 1998; 28: 273-97
5. Nicholson HS, Fears TR, Byrne J. Death during adulthood in survivors of childhood and adolescent cancer. Cancer 1994; 73: 3094-102
6. Robertson CM, Hawkins MM, Kingston JE. Late deaths and survival after childhood cancer: implications for cure. BMJ 1994; 309: 162-6
7. Hudson MM, Jones D, Boyett J, Sharp GB, Pui C-H. Late mortality of long-term survivors of childhood cancer. J Clin Oncol 1997; 15: 2205-13
8. Mertens A, Neglia J, Yasui Y, Potter J, Nesbit M Jr, Ruccione K, et al. Mortality rates and causes of death in 5-year survivors of childhood and adolescent cancer. Proceedings of the American Society of Clinical Oncology; 1999 May 15-18; Atlanta (GA). 1999; 18 (abstract)
9. Garrè ML, Gandus S, Cesana B, Haupt R, De Bernardi B, Comelli A, et al. Health status of long-term survivors after cancer in childhood. Results of an uniinstitutional study in Italy. Am J Pediatr Hematol Oncol 1994; 16: 143-52
10. Stevens MC, Mahler H, Parkes S. The health status of adult survivors of cancer in childhood. Eur J Cancer 1998; 34: 694-8
11. van der Does-van den Berg A, de Vaan GA, van Weerden JF, Hahlen K, van Weel-Sipman M, Veerman AJ. Late effects among long-term survivors of childhood acute leukemia in The Netherlands: a Dutch Childhood Leukemia Study Group Report. Pediatr Res 1995; 38: 802-7
12. Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol 1996; 26: 95-100
13. Parsons SK, Neault MW, Lehmann LE, Brennan LL, Eickhoff CE, Kretschmar CS, et al. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant 1998; 22: 669-74
14. Sklar C, La Quaglia MP. Rhabdomyosarcoma. In: Stringer MD, Oldham KT, Mouriquand PDE, Howard ER, editors. Pediatric surgery and urology: long term outcomes. London: WB Saunders Company Limited, 1998; 688-701